-transparent.png){kind=logo}
Naloxone has been shown to reverse the hemodynamic sequelae of experimental septic shock in adult animal models. Its effectiveness in the newborn has not been studied. To further investigate the efficacy of naloxone, we instrumented 18 piglets for continuous measurement of mean arterial pressure, mean pulmonary arterial pressure, central venous pressure, heart rate, left ventricular pressure, contractility, cardiac output, and O2. Oxygen consumption, systemic vascular resistance, and pulmonary vascular resistance were calculated. Following a stabilization period, group B beta-hemolytic Streptococci were infused over 30 min. Following the infusion, naloxone (1 mg/kg) was given followed by a continuous infusion of 1 mg/kg/h in nine treatment animals. Nine control animals were given an equal volume of saline. Both groups developed significant increases in mean pulmonary arterial pressure followed by a return to baseline. Oxygen consumption, cardiac output, contractility and mean arterial pressure decreased in both groups. Treatment with naloxone was associated with a cessation in the fall in the mean arterial pressure and the contractility. The difference in mean arterial pressure and contractility between groups was significant. The naloxone group had significantly improved 5-h survival. We speculate that naloxone may reverse some of the hemodynamic sequelae and improve survival in newborns with septic shock.
R R Miller, and
J A Menke, and
N B Hansen, and
D L Zwick, and
R G Bickers, and
P T Nowicki
March 1981,
Lancet (London, England),
R R Miller, and
J A Menke, and
N B Hansen, and
D L Zwick, and
R G Bickers, and
P T Nowicki
July 1955,
The American journal of physiology,
R R Miller, and
J A Menke, and
N B Hansen, and
D L Zwick, and
R G Bickers, and
P T Nowicki
January 1986,
Developmental pharmacology and therapeutics,
R R Miller, and
J A Menke, and
N B Hansen, and
D L Zwick, and
R G Bickers, and
P T Nowicki
February 1986,
Archives francaises de pediatrie,
R R Miller, and
J A Menke, and
N B Hansen, and
D L Zwick, and
R G Bickers, and
P T Nowicki
November 1988,
Lancet (London, England),
R R Miller, and
J A Menke, and
N B Hansen, and
D L Zwick, and
R G Bickers, and
P T Nowicki
January 1990,
Critical care medicine,
R R Miller, and
J A Menke, and
N B Hansen, and
D L Zwick, and
R G Bickers, and
P T Nowicki
April 1983,
Annals of internal medicine,
R R Miller, and
J A Menke, and
N B Hansen, and
D L Zwick, and
R G Bickers, and
P T Nowicki
March 1981,
Lancet (London, England),
R R Miller, and
J A Menke, and
N B Hansen, and
D L Zwick, and
R G Bickers, and
P T Nowicki
August 1983,
Critical care medicine,
R R Miller, and
J A Menke, and
N B Hansen, and
D L Zwick, and
R G Bickers, and
P T Nowicki
October 1985,
Lancet (London, England),
